JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB256081

Recombinant human CCL3 / MIP-1 alpha (Active)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant human CCL3 / MIP-1 alpha (Active) is a Human Full Length protein, in the 23 to 92 aa range, expressed in Escherichia coli, with >95%, <1 EU/µg endotoxin level, suitable for SDS-PAGE, FuncS.

View Alternative Names

G0S19-1, MIP1A, SCYA3, CCL3, C-C motif chemokine 3, G0/G1 switch regulatory protein 19-1, Macrophage inflammatory protein 1-alpha, PAT 464.1, SIS-beta, Small-inducible cytokine A3, Tonsillar lymphocyte LD78 alpha protein, MIP-1-alpha

1 Images
SDS-PAGE - Recombinant human CCL3 / MIP-1 alpha (Active) (AB256081)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant human CCL3 / MIP-1 alpha (Active) (AB256081)

SDS-PAGE analysis of ab256081 (1 μg) under non-reducing (Lane 1) and reducing (Lane 2) conditions. ab256081 is a homodimer with a predicted MW of 36.4 (monomer id 18.2 kDa).

4-20% Tris-Glycine gel. Coomassie Blue staining.

Key facts

Purity

>95% SDS-PAGE

Endotoxin level

<1 EU/µg

Expression system

Escherichia coli

Tags

Tag free

Applications

FuncS, SDS-PAGE

applications

Biologically active

Yes

Biological activity

(1) THP-1 chemotaxis (2) Human PBMC chemotaxis.

Accession

P10147

Animal free

No

Carrier free

No

Species

Human

Reconstitution

Reconstitute at 0.1 mg/mL in water

Storage buffer

Constituents: 0.1% Trifluoroacetic acid

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"linker":null,"sequence":"ASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA","proteinLength":"Full Length","predictedMolecularWeight":"7.8 kDa","actualMolecularWeight":null,"aminoAcidEnd":92,"aminoAcidStart":23,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P10147","tags":[]}]

Properties and storage information

Form
Lyophilized
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
True

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MIP-1 alpha also known as CCL3 or macrophage inflammatory protein 1 alpha is a chemokine with an approximate mass of 10 kDa. It is involved in the immune response by attracting and activating various immune cells such as macrophages and neutrophils. MIP-1 alpha is expressed in a variety of tissues including lymphoid organs inflammatory sites and activated macrophages. This chemokine plays a role in the recruitment of immune cells to the site of infection or injury aiding in the body’s defense mechanisms.
Biological function summary

The regulation of immune cell trafficking involves MIP-1 alpha which acts in both autocrine and paracrine manners. This chemokine functions within a chemokine network facilitating cell signaling pathways necessary for inflammatory responses. MIP-1 alpha does not typically form a complex but operates in close association with other chemokines like MIP-1 beta and RANTES to coordinate immune response.

Pathways

MIP-1 alpha functions prominently in the chemokine signaling pathway and MAPK cascade. It influences the activation of pathways leading to inflammation and leukocyte migration. In interaction MIP-1 alpha is associated with proteins like CCR5 a receptor that mediates its effects on immune cells. These pathways underline its role in orchestrating immune responses required for effective pathogen clearance and inflammation regulation.

MIP-1 alpha associates closely with inflammatory diseases such as rheumatoid arthritis and multiple sclerosis. In rheumatoid arthritis elevated levels of MIP-1 alpha contribute to joint inflammation and pain. Additionally it interacts with proteins like TNF-alpha exacerbating inflammatory processes. MIP-1 alpha’s involvement in autoimmune and inflammatory diseases highlights its potential as a target for therapeutic interventions aimed at modulating immune responses for better disease management.

General info

Function

Monokine with inflammatory and chemokinetic properties. Binds to CCR1, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-alpha induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV).

Sequence similarities

Belongs to the intercrine beta (chemokine CC) family.

Post-translational modifications

N-terminal processed form LD78-alpha(4-69) is produced by proteolytic cleavage after secretion from HTLV1-transformed T-cells.

Product protocols

Target data

Monokine with inflammatory and chemokinetic properties. Binds to CCR1, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-alpha induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV).
See full target information CCL3

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com